Challenges and Choice: An audit of the management of nausea, vomiting and bowel obstruction in metastatic ovarian cancer
References
Camilleri M (2007) Management of Malignant Bowel Obstruction. Paper: Hospice New Zealand Breakfast Teleconference, 3 May 2007, Palmerston North, NZ.
Cooper R and Gent P (2002) An overview of chemotherapy – induced emesis highlighting the role of lorazepam as adjuvant therapy, International Journal of Palliative Nursing 8(7): 331-335.
EClinic Pty Ltd (2007) PalCare: an introduction Accessed at http://www.eclinic.com.auwww.eclinic.com.au on 30 June 2007.
Ferrell B, Cullinance CA, Ervin K, Melancon C, Uman GC and Juarez G (2005) Perspectives on the impact of ovarian cancer: women’s views on quality of life, Oncology Nursing Forum 32(6): 1143-1149.
Grundy K and Morgan A (2003) Christchurch Hospital Palliative Care service: Clinical Guidelines, Canterbury District Health Board, Christchurch, NZ.
Laval G, Arvieux C, Stefani L, Villard M-L, Mestrallet J-P and Cardin N (2006) Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Centre, Journal of Pain and Symptom Management 31(6): 502-512.
Letizia M and Norton E (2003) Successful management of malignant bowel obstruction, Journal of Hospice and Palliative Nursing 5(3): 152-158.
Levine ME, Gillis M, Yanchis S, Voss AC, Stern RM and Koch KL (2006) Protein and ginger for the treatment of chemotherapy induced delayed nausea and gastric dysrhythmia, Neurogastroenterology and Motility 18(6): 488-486.
Lockwood-Rayermann S (2006) Survivorship issues in ovarian cancer: a review, Oncology Nursing Forum 33(3): 553-562.
MacLeod RD, Vella-Brincat J and Macleod AD (2004) The Palliative Care Handbook 2nd edn, Genesis Oncology Trust, Wellington.
Mangli G, Aletti G, Frigerio L, Franch M, Panacci N, Vigano R, De Marzi P, Zanetto F and Ferrari A (2005) Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis, International Journal of Gynaecological Cancer 5(5): 830-835.
Manusirivithaya S, Sripramote M, Tangjitgamol S, Sheanakul C, Leelakahorn S, Thavarama T and Tangcharoenpanich K (2004) Anti-emetic effects of ginger in gynaecologic oncology patients receiving cisplatin, International Journal of Gynaecological Cancer 14(16): 1063-1069.
Martin GW (1998) Empowerment of dying patients: The strategies and barriers to patient autonomy, Journal of Advanced Nursing 28(4): 737-744.
Martin V (2005) Straight talk about ovarian cancer, Nursing 35(4): 36-42.
New Zealand Ministry of Health (2005) Cancer: New Registrations and Deaths 2001, accessed at http://www.moh.govt.nz on 7 May 2007.
New Zealand Ministry of Health (2006) Toward Clinical Excellence: An Introduction to Clinical Audit, Peer Review and Other Clinical Practice Improvement Activities, accessed at http://www.moh.govt.nz on 10 December 2006.
Ripamonti C and Bruera E (2002) Palliative management of malignant bowel obstruction, International Journal of Gynaecological Cancer 12(2): 135-143.
Thompson I (2004) The management of nausea and vomiting in palliative care, Nursing Standard 19(8): 46-53.
Twycross R and Wilcock A (2001) Symptom Management in Advanced Care 3rd edn, Radcliffe Medical Press, Abingdon.
eContent Home
